AI Medicine Could be First to Treat Disease With No Cure in a New Way

An AI-designed medicine for Inflammatory Bowel Disease enters Phase 1 clinical trials. Artificial Intelligence Biotech Company, Insilico Medicine, has reportedly entered the first phase of its clinical trials for the ISM5411.

Related Keywords

Pessac ,Aquitaine ,France ,China ,United States ,Australia ,Alex Zhavoronkov ,Aldohn Domingo ,Dana Farber Cancer Institute Under Scrutiny ,Allegations Of Research Misconduct ,Bloomberg ,Artificial Intelligence Biotech Company ,Tech Times ,Intelligence Biotech Company ,Insilico Medicine ,Inflammatory Bowel Disease ,Getty Images ,Treefrog Therapeutics ,Powered Device ,Detect All ,Research Misconduct Unearthed ,Ai ,Artificial Intelligence ,Ki Medicine ,Nai Drug ,I Chemistry42 ,Ai Technology ,I Pharmaceutics ,I Designed Drug ,I Development ,Pharmaceuticals ,Harmaceutical ,Biotech ,Biotechnology ,Inflammatory Bowel Diseases ,Bd ,